Search results
Results From The WOW.Com Content Network
Phenylephrine, sold under the brand names Neosynephrine and Sudafed PE among numerous others, is a medication used as a decongestant for uncomplicated nasal congestion, [5] used to dilate the pupil, used to increase blood pressure (given intravenously in cases of low blood pressure), and used to relieve hemorrhoids (as a suppository).
Phenylephrine is an oral medication primarily used as a decongestant. [5] [6] It is a selective α 1-adrenergic receptor activator which results in the constriction of both arteries and veins. [5] Common side effects include nausea, headache, and anxiety. [5] Phenylephrine was patented in 1927 and came into medical use in 1938. [7]
Products. Their original and best-known product is a lemon -flavoured hot drink containing 650 mg of paracetamol (an analgesic), and 10 mg phenylephrine hydrochloride (a decongestant) to help to relieve headache, fever, blocked nose, body aches and pains, and a sore throat. [1] In 1995 the Lemsip Max range was launched which included lemon ...
As Yahoo Life reported last year, when taken in oral form, phenylephrine is metabolized so quickly that the amount absorbed into the bloodstream ends up being less than 1% of what was originally ...
Tylenol is a brand of drugs advertised for reducing pain, reducing fever, and relieving the symptoms of allergies, cold, cough headache, and influenza. The active ingredient of its original flagship product is paracetamol. The brand name "Tylenol" is owned by McNeil Consumer Healthcare, [1] a subsidiary of Kenvue. As of 2017 the brand was used ...
For premium support please call: 800-290-4726 more ways to reach us
Guaifenesin, also known as glyceryl guaiacolate, is an expectorant medication taken by mouth and marketed as an aid to eliminate sputum from the respiratory tract. Chemically, it is an ether of guaiacol and glycerine. It may be used in combination with other medications. [4]
It contains phenylephrine and ketorolac. [ 1 ] Phenylephrine/ketorolac was approved for medical use in the United States in May 2014, [ 4 ] and in the European Union in July 2015.